KKESH becomes the first hospital in the Middle East to revalidate as EMRAM Stage 7, the prestigious global recognition for use of health informatics
RIYADH, SAUDI ARABIA (20 July 2020) – King Khaled Eye Specialist Hospital (KKESH) has announced that it has revalidated as Stage 7 on the HIMSS Electronic Medical Record Adoption Model (EMRAM).
KKESH was the first hospital in the Middle East to obtain EMRAM Stage 7 and is now the first to renew the Stage 7 validation and achieve this prestigious global recognition for improving patient care through advanced EMR maturity.
This designation indicates that the hospital is employing the highest level of clinical information technology and advanced safety features to provide excellent patient care. The requirements have become even more rigorous since KKESH first achieved Stage 7 in 2016.
KKESH demonstrated significant quality of care and efficiency improvements following the implementation of InterSystems TrakCare® unified health information system, which helped KKESH achieve EMRAM Stage 6 just five months after deployment. The hospital then moved from Stage 6 to Stage 7 in less than two years.
TrakCare provided KKESH with a unified healthcare information system, consolidating all patient administration, financial, and clinical information in a single data repository with a common user interface, while also integrating KKESH’s other systems.
Dr. Abdulaziz bin Ibrahim Al-Rajhi, chief executive officer of King Khaled Eye Specialist Hospital, confirmed that this hospital's Stage 7 revalidation is in line with the hospital’s leadership strategy to transform KKESH into a digital smart hospital so that it can help achieve one of the goals of the Saudi 2030 vision of national digital transformation in the healthcare sector.
“The support and continuous communication with His Excellency the Minister of Health contributed to the hospital’s success in implementing many programs and plans, especially in the field of developing electronic services to obtain an easier and more advanced service,” said Dr. Al-Rajhi. “The ongoing support from the health sector leadership is enabling us to overcome all obstacles and helping the healthcare sector in providing and developing its services to all our citizens.”
Commenting on this global recognition, John Rayner, HIMSS regional director, EMEA, said, “This is a great hospital absolutely committed to using technology to increase patient safety and the overall patient experience. To maintain this high standard over so many years, right up to the point of revalidation, is real testimony to those responsible for developing, deploying and customising the TrakCare EPR from Intersystems.”
“We are proud that KKESH has renewed its well-deserved HIMSS EMRAM Stage 7 validation. This prestigious recognition reconfirms the excellent teamwork between KKESH and InterSystems teams and reflects the advancements in patient care the hospital has achieved by using TrakCare,” said Ali Abi Raad, country manager for the Middle East and India at InterSystems.
For more information about EMRAM, visit: https://middleeast.himssanalytics.org/middle-east/electronic-medical-rec...
About King Khaled Eye Specialist Hospital
King Khaled Eye Specialist Hospital (KKESH) is a tertiary care ophthalmic facility operated by the Ministry of Health (MOH) of the Kingdom of Saudi Arabia. The hospital provides quality tertiary ophthalmic care to the patients it serves and promotes the delivery of Kingdom-wide ophthalmic care through its outreach, educational, and research programs. For more than three decades, KKESH has been recognized for excellence in its delivery of ophthalmic patient care, for its strong educational and international research programs (including continuing medical education seminars and symposia and training of ophthalmology residents and subspecialty fellows and other allied healthcare professionals). For more information, visit www.kkesh.med.sa.
InterSystems is the engine behind the world’s most important applications. In healthcare, finance, government, and other sectors where lives and livelihoods are at stake, InterSystems is the power behind what mattersTM. Founded in 1978, InterSystems is a privately held company headquartered in Cambridge, Massachusetts (USA), with offices worldwide, and its software products are used daily by millions of people in more than 80 countries. For more information, visit InterSystems.com.
HIMSS is a global advisor and thought leader supporting the transformation of the health ecosystem through information and technology. As a mission driven non-profit, HIMSS offers a unique depth and breadth of expertise in health innovation, public policy, workforce development, research and analytics to advise global leaders, stakeholders and influencers on best practices in health information and technology. Through our innovation engine, HIMSS delivers key insights, education and engaging events to healthcare providers, governments and market suppliers, ensuring they have the right information at the point of decision. Headquartered in Chicago, Illinois, HIMSS serves the global health information and technology communities with focused operations across North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. Our members include more than 80,000 individuals, 480 provider organizations, 470 non-profit partners and 650 health services organizations.